A 4-year-old boy with tuberous sclerosis complex presents with progressive headaches and vomiting over 2 weeks. MRI brain shows the lesion marked **C** in the diagram, which has grown to 15 mm and is causing obstruction at the foramen of Monro. Which of the following is the most appropriate next step in management?
A. Observation with serial imaging every 6 months
B. Immediate surgical resection
C. Everolimus (mTOR inhibitor) therapy
D. Vigabatrin monotherapy
Explanation
Why Everolimus is right
The structure marked C is a subependymal giant cell astrocytoma (SEGA) at the foramen of Monro. According to the International TSC Consensus Criteria 2021, SEGAs arise from unrestrained mTOR signaling due to loss of TSC1/TSC2 function. Everolimus, an mTOR inhibitor, is FDA-approved for SEGAs not amenable to surgery and can halt or regress tumor growth, preventing obstructive hydrocephalus. In this case, the patient is symptomatic (headaches, vomiting) from obstruction, making medical management with everolimus the first-line targeted therapy before considering surgery.
Why each distractor is wrong
Immediate surgical resection: While surgery is an option for SEGAs causing symptomatic hydrocephalus, everolimus is now the preferred first-line targeted therapy for growing SEGAs. Surgery is reserved for cases refractory to mTOR inhibition or acute decompensation.
Vigabatrin monotherapy: Vigabatrin is the drug of choice for TSC-associated infantile spasms (seizures), not for SEGA management. It has no role in controlling SEGA growth or preventing hydrocephalus.
Observation with serial imaging every 6 months: This patient is symptomatic with obstructive hydrocephalus (headaches, vomiting) and a growing SEGA. Observation is inappropriate; active intervention with everolimus is indicated to prevent neurological deterioration.
High-YieldNEET PG
Everolimus (mTOR inhibitor) is the breakthrough targeted therapy for TSC-related SEGAs not amenable to surgery—it halts growth and prevents obstructive hydrocephalus.
International TSC Consensus Diagnostic & Surveillance Criteria 2021
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
